Literature DB >> 172111

Partial myeloperoxidase deficiency in a case of preleukaemia. I. Studies of fine structure and peroxidase synthesis of promyelocytes.

J Breton-Gorius, D Houssay, B Dreyfus.   

Abstract

The ultrastructural localization of peroxidase activity has been studied in the circulating neutrophils and in a neutrophilic series of bone marrow cells from a patient with preleukaemia. Light microscopic examination showed 36% of the polymorphonuclear leucocytes to be totally devoid of myeloperoxidase, while 50% were normally stained and 14% were slightly positive for this enzyme. Electron microscopic studies revealed considerable heterogeneity in the promyelocyte population, since the number of peroxidase-deficient azurophil granules was seen to vary from 0 to 100% in these cells. Thus, several types of promyelocytes were identified. One cell type, which resembled that seen in normal subjects, contained myeloperoxidase within its azurophil granules and also within the cisternae of the rough endoplasmic reticulum and Golgi complex. A second type of promyelocyte, which was at an early stage of development, lacked myeloperoxidase in its secretory apparatus. These cells contained two species of azurophil granules, the first of which was devoid of peroxidase activity whereas the other reacted positively. These observations suggest that the premature arrest of myeloperoxidase synthesis in the promyelocytes from a preleukaemic patient may give rise to several populations of circulating neutrophils which can exhibit varying contents of myeloperoxidase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172111     DOI: 10.1111/j.1365-2141.1975.tb00542.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Monocyte function in patients with myelodysplastic syndrome.

Authors:  Daniel A Pollyea; Brenna R Hedin; Brian P O'Connor; Scott Alper
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

2.  Lactoferrin-deficient neutrophil polymorphonuclear leucocytes in leukaemias: a semiquantitative and ultrastructural cytochemical study.

Authors:  J Miyauchi; Y Watanabe; Y Enomoto; K Takeuchi
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

3.  Phagocytosis of neutrophil polymorphonuclears by macrophages in human bone marrow: importance in granulopoiesis.

Authors:  C Dresch; G Flandrin; J Breton-Gorius
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

4.  Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture.

Authors:  K N Prasad; P K Sinha; M Ramanujam; A Sakamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

5.  Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species.

Authors:  K R Johnson; W M Nauseef; A Care; M J Wheelock; S Shane; S Hudson; H P Koeffler; M Selsted; C Miller; G Rovera
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

6.  Neutrophil function and diagnosis of pre-leukaemic states.

Authors:  J B Houghton
Journal:  Postgrad Med J       Date:  1979-06       Impact factor: 2.401

7.  Inhibition of myeloperoxidase by salicylhydroxamic acid.

Authors:  B Davies; S W Edwards
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

8.  Development of the granule population in neutrophil granulocytes from human bone marrow.

Authors:  P Brederoo; J van der Meulen; A M Mommaas-Kienhuis
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

9.  Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Detection by immunoperoxidase staining for lactoferrin and cytochemical electron microscopy.

Authors:  J Breton-Gorius; D Y Mason; D Buriot; J L Vilde; C Griscelli
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307

10.  Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders.

Authors:  S Martin; S C Baldock; A T Ghoneim; J A Child
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.